Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA

By Lentz S.R.   Rodionov R.N.   Dayal S.  

Atherosclerosis, Supplements, Vol. 4, Iss. 4, 2003-12 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction

By Paroni R.   Barassi A.   Ciociola F.   Dozio E.   Finati E.   Fermo I.   Ghilardi F.   Colpi G. M.   Corsi M. M.   Melzi d’Eril G. V.  

International Journal of Andrology, Vol. 35, Iss. 5, 2012-10 ,pp. : 660-667

Blackwell Publishing

Access to resources Recommend Favorite

On the Role of Endothelial TRPC3 Channels in Endothelial Dysfunction and Cardiovascular Disease

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 3, 2012-09 ,pp. : 265-274

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study

By Erre Gian   Sanna Pietro   Zinellu Angelo   Ponchietti Alessandra   Fenu Patrizia   Sotgia Salvatore   Carru Ciriaco   Ganau Antonello   Passiu Giuseppe  

Clinical Rheumatology, Vol. 30, Iss. 1, 2011-01 ,pp. : 21-27

Springer Publishing Company

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase

By Boger R.H.   Vallance P.   Cooke J.P.  

Atherosclerosis, Supplements, Vol. 4, Iss. 4, 2003-12 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite